2
Views
5
CrossRef citations to date
0
Altmetric
Review

Management of TB during pregnancy, especially in high-risk communities

Pages 555-563 | Published online: 10 Jan 2014
 

Abstract

Tuberculosis is a common illness in the world, especially in sub-Saharan Africa, the Indian subcontinent, the former Soviet Union states and China. In western Europe and North America, TB remains common in those with concurrent HIV infection, the homeless and those with drug and alcohol addiction. In pregnancy, the symptoms of TB may be confused with normal features of pregnancy. Sputum examination and a shielded chest x-ray are appropriate tests in those at a high risk of active TB. Extrapulmonary TB is more common in women and in pregnancy, and diagnosis may be delayed. Tuberculin skin testing and the new blood tests (IFN-γ-release assays) may be useful in these circumstances and also in the diagnosis of latent TB. HIV coinfection is an important cause of mortality and morbidity. Treatment of TB in pregnancy is safe and reduces the fetal complications associated with active disease. Chemoprophylaxis for latent TB infection may also be taken during pregnancy. Drug-resistant TB is an increasing problem in individuals from sub-Saharan Africa and eastern Europe, with a high mortality rate. Treatment with aminoglycosides is associated with fetal hearing and occasional balance problems, but the adverse effects of other second-line drugs are not well documented. The implications of infection control following the diagnosis of TB in pregnancy should be met with a well-planned response. Bacillus Calmette–Guérin vaccination should be given to neonates where the incidence of TB is greater than 40 per 100,000, unless they have HIV coinfection. TB is an important cause of infertility.

Financial & competing interests disclosure

The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.